Best Evidence Summary for the Management of Frailty in Elderly Patients in Emergency Department-Integrative Review
Abstract
Aim: To systematically search, evaluate and synthesize the most robust evidence regarding the management of frailty in elderly patients in the emergency department.
Design: This study was conducted as an evidence summary, strictly adhering to the reporting standards for evidence summaries developed by the Center for Evidence-Based Nursing, Fudan University.
Data sources: UpToDate, BMJ Best Practice, JBI, National Guideline Clearing-house, Guidelines International Network, Scottish Intercollegiate Guidelines Network, National Institute for Health and Care Excellence, Registered Nurses Association of Ontario, Yi Mai tong Guidelines Network, the Cochrane Library, PubMed, Web of Science, Embase, OVID, Sinomed, CNKI, Wan Fang database. The search was conducted from the inception of each database to June 2025.
Review methods: Evidence was selected using predefined eligibility criteria, critically appraised with AGREE II, AMSTAR 2, and Joanna Briggs Institute tools as appropriate, and synthesized using the JBI evidence classification and recommendation system. Study selection, appraisal and evidence extraction were undertaken independently by trained reviewers, with disagreements resolved through discussion or third-reviewer adjudication.
Results: After rigorous screening and evaluation, 13 high-quality articles were identified, including 3 clinical guidelines, 1 randomized controlled trial (RCT), 2 clinical decision-making studies, 2 expert consensus documents, 2 cohort studies…
Read the paper
Related studies
- The Matrisome: In Silico Definition and In Vivo Characterization by Proteomics of Normal and Tumor Extracellular Matrices
- The Escherichia coli MG1655 in silico metabolic genotype: Its definition, characteristics, and capabilities
- In silico pharmacology for drug discovery: methods for virtual ligand screening and profiling
- In silico prediction of splice-altering single nucleotide variants in the human genome
- In silico clinical trials: how computer simulation will transform the biomedical industry
- In silico optimization of a guava antimicrobial peptide enables combinatorial exploration for peptide design
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.